Your browser doesn't support javascript.
loading
Anticolitic Effect of the Rhizome Mixture of Anemarrhena asphodeloides and Coptidis chinensis (AC-mix) in Mice
Article en En | WPRIM | ID: wpr-108272
Biblioteca responsable: WPRO
ABSTRACT
During a screening program to search the anticolitic herbal medicines, 80% ethanol extract of the rhizome of Anemarrhena asphodeloides (AA) was found to potently inhibit the expression of proinflammatory cytokines TNF-alpha and IL-1beta, as well as the activation of NF-kappaB in LPS-stimulated colonic macrophages, followed by that of the rhizome of C. chinensis (CC). AA also potently inhibited TNBS-induced colitic markers, shortening of the colon and increase of macroscopic score, myeloperoxidase activity, TNF-alpha, IL-1beta, and IL-6, in mice. The synergistic effect of CC against the anticolitic effect of AA was investigated. CC synergistically inhibited the anticolitic effect of AA. AC-mix (AA+CC, 1:1) potently inhibited them. AC-mix also inhibited the activation of NF-kappaB, as well as the expression of TNF-alpha, IL-1beta, IL-6, iNOS and COX-2. The effects of AC-mix against oxazolone-induced colitis were investigated in mice. AC-mix also potently inhibited oxazolone-induced inflammatory markers, colon shortening, macroscopic score, myeloperoxidase activity, NF-kappaB activation and proinflammatory cytokines. Overall, the anti-colitic effect of AC-mix was superior to that of mesalazine. Based on these findings, AC-mix may improve colitis by inhibiting NF-kappaB activation.
Asunto(s)
Palabras clave
Texto completo: 1 Índice: WPRIM Asunto principal: Tamizaje Masivo / Citocinas / FN-kappa B / Interleucina-6 / Factor de Necrosis Tumoral alfa / Colitis / Colon / Peroxidasa / Mesalamina / Rizoma Tipo de estudio: Prognostic_studies / Screening_studies Límite: Animals Idioma: En Revista: Biomolecules & Therapeutics Año: 2013 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Asunto principal: Tamizaje Masivo / Citocinas / FN-kappa B / Interleucina-6 / Factor de Necrosis Tumoral alfa / Colitis / Colon / Peroxidasa / Mesalamina / Rizoma Tipo de estudio: Prognostic_studies / Screening_studies Límite: Animals Idioma: En Revista: Biomolecules & Therapeutics Año: 2013 Tipo del documento: Article